Free Trial

Landore Resources (LND) Competitors

Landore Resources logo
GBX 3.91 -0.09 (-2.25%)
(As of 12/20/2024 12:01 PM ET)

LND vs. AVO, FDP, TED, AFRK, FAR, CUSN, ATM, ZNWD, CTL, and GSP

Should you be buying Landore Resources stock or one of its competitors? The main competitors of Landore Resources include Advanced Oncotherapy (AVO), FD Technologies (FDP), Ted Baker (TED), Afarak Group (AFRK), Ferro-Alloy Resources (FAR), Cornish Metals (CUSN), Andrada Mining (ATM), Zinnwald Lithium (ZNWD), CleanTech Lithium (CTL), and Gensource Potash (GSP).

Landore Resources vs.

Advanced Oncotherapy (LON:AVO) and Landore Resources (LON:LND) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, media sentiment, earnings, analyst recommendations, profitability, risk and community ranking.

In the previous week, Advanced Oncotherapy's average media sentiment score of 0.00 equaled Landore Resources'average media sentiment score.

Company Overall Sentiment
Advanced Oncotherapy Neutral
Landore Resources Neutral

Advanced Oncotherapy received 122 more outperform votes than Landore Resources when rated by MarketBeat users. Likewise, 60.97% of users gave Advanced Oncotherapy an outperform vote while only 57.76% of users gave Landore Resources an outperform vote.

CompanyUnderperformOutperform
Advanced OncotherapyOutperform Votes
189
60.97%
Underperform Votes
121
39.03%
Landore ResourcesOutperform Votes
67
57.76%
Underperform Votes
49
42.24%

Advanced Oncotherapy's return on equity of -67.34% beat Landore Resources' return on equity.

Company Net Margins Return on Equity Return on Assets
Advanced OncotherapyN/A -67.34% -11.73%
Landore Resources N/A -207.95%-106.31%

Advanced Oncotherapy has a beta of 0.06, indicating that its share price is 94% less volatile than the S&P 500. Comparatively, Landore Resources has a beta of -0.15, indicating that its share price is 115% less volatile than the S&P 500.

Landore Resources is trading at a lower price-to-earnings ratio than Advanced Oncotherapy, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Advanced OncotherapyN/AN/A-£32.60M-£0.07N/A
Landore ResourcesN/AN/A-£1.77M-£0.01-391.00

17.8% of Advanced Oncotherapy shares are held by institutional investors. Comparatively, 3.2% of Landore Resources shares are held by institutional investors. 47.5% of Advanced Oncotherapy shares are held by insiders. Comparatively, 39.6% of Landore Resources shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Advanced Oncotherapy beats Landore Resources on 8 of the 10 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LND vs. The Competition

MetricLandore ResourcesOther Industrial Metals & Mining IndustryMaterials SectorLON Exchange
Market Cap£12.23M£847.77M£2.84B£1.88B
Dividend Yield6.74%6.19%5.02%5.49%
P/E Ratio-391.0058.88112.721,839.28
Price / SalesN/A54,859.15798,818.38388,735.88
Price / Cash21.0025.0224.3928.66
Price / Book3.912.383.412.78
Net Income-£1.77M£57.93M£152.72M£155.55M
7 Day PerformanceN/A-2.66%-2.91%-2.01%
1 Month Performance13.01%17.00%1.16%21.39%
1 Year Performance22.38%24.58%17.14%29.37%

Landore Resources Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LND
Landore Resources
N/AGBX 3.91
-2.3%
N/A+24.1%£12.23MN/A-391.006High Trading Volume
AVO
Advanced Oncotherapy
N/AGBX 1.75
-9.1%
N/AN/A£9.50MN/A-25.003,900Gap Down
FDP
FD Technologies
N/AGBX 1,906
-0.2%
N/A+73.7%£537.87M£248.86M-3,979.1740,100
TED
Ted Baker
N/AGBX 109.80
flat
N/AN/A£202.71M£428.24M-5.69740News Coverage
AFRK
Afarak Group
N/AGBX 20
flat
N/A+0.0%£52.20M£129.75M666.67588News Coverage
FAR
Ferro-Alloy Resources
N/AGBX 9.75
+9.6%
N/A+31.6%£47.11M£4.55M-890.001,000News Coverage
Gap Up
CUSN
Cornish Metals
N/AGBX 8.80
-2.8%
N/A-15.4%£47.10MN/A1,150.00N/AGap Down
ATM
Andrada Mining
2.1634 of 5 stars
GBX 2.43
-3.4%
GBX 11
+353.6%
-57.6%£40.01M£17.97M-242.50219News Coverage
ZNWD
Zinnwald Lithium
N/AGBX 8.20
0.0%
N/A+8.5%£38.89MN/A-825.0023Gap Down
CTL
CleanTech Lithium
N/AGBX 18.32
+0.4%
N/A-15.6%£26.59MN/A-456.2520
GSP
Gensource Potash
N/AGBX 5.25
flat
N/AN/A£23.61MN/A-525.00N/A

Related Companies and Tools


This page (LON:LND) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners